ArticleThe Journal of infection2020
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study.
Abstract readLetterComment
In one paragraph
Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence of Coronavirus Disease 2019 (COVID-19) in Different Clinical Stages before the National COVID-19 Vaccination Programme in Malaysia: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022Pooled it
- Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Calcium channel blockers may reduce the development of long COVID in females.Hypertension research : official journal of the Japanese Society of Hypertension · 2024Article
- Review
- Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.BMC pulmonary medicine · 2023Article
- Descriptive epidemiology of COVID-19 in Japan 2020: insights from a multihospital database.Annals of clinical epidemiology · 2023Article
- Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19.The American journal of the medical sciences · 2022Article
- Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population.International journal of immunogenetics · 2022Article
- Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics.BMC infectious diseases · 2022Article
- Article
- U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan.The Lancet regional health. Western Pacific · 2022Article
- Activity of daily life dependency predicts the risk of mortality in patients with COVID-19 undergoing hemodialysis: a retrospective analysis of a single center with nosocomial outbreak.Renal replacement therapy · 2022Article
- Finding of the factors affecting the severity of COVID-19 based on mathematical models.Scientific reports · 2021Article
- Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.BMJ open respiratory research · 2021Article
- Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population.Hypertension (Dallas, Tex. : 1979) · 2021Article
- Clinical Characteristics and Risk Factors for Severe Outcomes of Novel Coronavirus Infection, January-March 2020, Japan.Journal of epidemiology · 2021Article
- Risk factors for the delayed viral clearance in COVID-19 patients.Journal of clinical hypertension (Greenwich, Conn.) · 2021Article
- Epidemiology of Coronavirus Disease 2019 in Japan: Descriptive Findings and Lessons Learned through Surveillance during the First Three Waves.JMA journal · 2021Article
- Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.BMC anesthesiology · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
27 authors.
Makoto IshiiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hideki TeraiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Division of Translational Research, Clinical and Translational Research Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hiroki KabataDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Katsunori MasakiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Shotaro ChubachiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hiroki TatenoDepartment of Pulmonary Medicine, Saitama City Hospital, 2460 Mimuro, Midori-ku, Saitama City, Saitama 336-8522, Japan.
Morio NakamuraDepartment of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, 1-4-17, Mita, Minato-ku, Tokyo 108-0073, Japan.
Kazumi NishioDepartment of Pulmonary Medicine, Kawasaki Municipal Ida Hospital, 2-27-1, Ida, Nakahara-ku, Kawasaki-shi, Kanagawa 211-0035, Japan.
Hidefumi KohDivision of Pulmonary Medicine, Department of Internal Medicine, Federation of National Public Service Personnel Mutual Aid Associations, Tachikawa Hospital, 4-2-22, Nishiki-cho, Tachikawa-shi, Tokyo 190-8531, Japan.
Risa WatanabeDepartment of Respiratory Medicine, National Hospital Organization Tokyo Medical Center, 2-5-1, Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Soichiro UedaDepartment of Internal Medicine, Saitama Medical Center, 4-9-3, Kitaurawa, Urawa-ku, Saitama-shi, Saitama 330-0074, Japan.
Takeshi TerashimaDepartment of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, 5-11-13, Sugano, Ichikawa-shi, Chiba, Japan Chiba 272-0824, Japan.
Yusuke SuzukiDepartment of Medicine, Kitasato University Kitasato Institute Hospital, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8642, Japan.
Kazuma YagiDepartment of Internal Medicine, Keiyu Hospital, 3-7-3, Minatomirai, Nishi-ku, Yokohama-shi, Kanagawa 220-8521, Japan.
Naoki MiyaoDepartment of Internal Medicine, Nihon Koukan Hospital, 1-2-1, Koukan-douri, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0852, Japan.
Naoto MinematsuDepartment of Internal Medicine, Hino Municipal Hospital, 4-3-1, Tamadaira, Hino-shi, Tokyo 191-0062, Japan.
Takashi InoueSano Kousei General Hospital, 1728 Horigome-cho, Sano-shi, Tochigi 327-8511, Japan.
Ichiro NakachiPulmonary Division, Department Internal Medicine, Saiseikai Utsunomiya Hospital, 911-1, Takebayashi-machi, Utsunomiya-shi, Tochigi 321-0974, Japan.
Ho NamkoongDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 11S261, Bethesda, MD 20814, USA.
Satoshi OkamoriDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Shinnosuke IkemuraDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hirofumi KamataDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hiroyuki YasudaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Ichiro KawadaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Naoki HasegawaDepartment of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Koichi FukunagaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: kfukunaga@keio.jp.
Keio COVID-19 Research Consortium (K-CORC) and the Keio Donner Project Team
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralSevere Acute Respiratory SyndromeBetacoronavirusCOVID-19HumansJapanRetrospective StudiesRisk FactorsSARS-CoV-2COVID-19JapanRetrospective studyRisk factorsSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.